NASDAQ · Medical - Pharmaceuticals

MEDS (MEDS) Stock

$3.00 -15.49% NASDAQ: MEDS Healthcare

Valuation

MetricValue
Price$3.00
Market Cap$7.39M
P/E Ratio-3.10
P/B Ratio0.05
P/S Ratio0.03
EPS (TTM)$-2.70
52-Week High$44.56
52-Week Low$3.00
Dividend Yield1.25%

Financials & Margins

MetricValue
ROE-121.12%
ROA-51.47%
ROCE-60.38%
Gross Margin78.97%
Operating Margin-10071.06%
Net Margin-9.72%
Debt/Equity0.00
Current Ratio1.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$11.0M$8.0M$0$432.0M
Operating Profit$-5.0M$-3.0M$-7.0M$-19.0M$-43.5B
Net Profit$-4.0M$-4.0M$-18.0M$9.0M$-42.0M
EPS$-7.58$-7.63$-7.49$2.48$-2.70
Op Margin-53.5%-24.1%-87.8%-13743.0%-10080.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$4.0M$13.0M$105.0M$84.2B
Total Liabilities$2.0M$3.0M$12.0M$26.0M$14.1B
Cash$3.0M$1.0M$0$0$6.7B
Borrowings$1.0M$2.0M$7.0M$3.0M$24.0M

Latest News

Wellgistics Health, Datavault AI Agree to Form DelivMeds AI MT Newswires · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-2.0M$-2.0M$-13.0M$-13.4B
Investing Cash Flow$0$-1.0M$0$28.0M$0
Financing Cash Flow$0$0$1.0M$2.0M$19.7B
Net Cash Flow$-3.0M$-2.0M$-1.0M$0$6.4B
Free Cash Flow$-3.0M$-2.0M$-2.0M$-13.0M$-13.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-3.90
FCF Yield-122704.48%
Quick Ratio1.63
Interest Coverage11.43
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held68.38%
Institutions Held1.70%
Institutions Float Held5.36%
Institutional HolderSharesReport Date
Geode Capital Management, LLC14,2162026-03-31
Vanguard Capital Management LLC12,0852026-03-31
Vanguard Fiduciary Trust Co6,1922026-03-31
State Street Corporation2,4922026-03-31
Jane Street Group, LLC1,8802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALGS $4.28 -1.04% -2.29 $26.45M 0.00%
BDSX $20.38 -3.09% -2.82 $165.90M 0.00%
BEAT $0.50 +0.98% -1.48 $17.10M 0.00%
INMB $1.73 +6.79% -2.44 $45.99M 0.00%
KZR $7.29 +0.00% -0.96 $53.86M 0.00%

About MEDS

MEDS is headquartered in US.

MEDS stock trades at $3.00 with a market capitalization of $7.39M. The stock is valued at a price-to-earnings (P/E) ratio of -3.10, price-to-book of 0.05, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $3.00 and $44.56, and currently trades 93.3% below its 52-week high. It pays a dividend yielding 1.25%.

On profitability, MEDS generates a return on equity (ROE) of -121.12%, return on capital employed of -60.38%, an operating margin of -10071.06%, a net profit margin of -9.72%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides